成人Evans综合征:一项观察性多中心研究
该回顾性国际研究分析了13个欧洲三级中心的116例成人Evans综合征患者,发现21%为继发性,42%发生出血,54%需≥3线治疗,感染和血栓发生率分别为33%和21%,且与治疗线数相关。
要点
- 成人Evans综合征常病情严重、复发频繁,需多线治疗。
- 感染和血栓并发症常见且与治疗线数相关。
- 起病时严重贫血、复发、感染和血栓与生存不良相关。
核心结论
- 成人Evans综合征常严重、复发,并发症可致命,需提高认识、及时治疗及抗感染/抗血栓预防。
研究设计与样本
- 回顾性国际研究,纳入13个欧洲三级中心的116例成人Evans综合征患者。
主要发现
- 24例(21%)为继发性或伴随其他疾病,主要为自身免疫病和血液肿瘤。
- 42%患者发生出血,主要为低级别且发生于ITP起病时。
- 几乎所有患者接受一线治疗(激素±静脉免疫球蛋白),23%因原发难治需早期额外治疗。
- 54%患者需≥3线治疗,感染和血栓并发症分别占33%和21%,主要为≥3级,与治疗线数相关。
- 除年龄外,起病时严重贫血、复发、感染和血栓对生存有负面影响。
关键数值与推荐
- 额外治疗包括利妥昔单抗、脾切除、免疫抑制剂、血小板生成素受体激动剂等,应答率>80%。
临床怎么用
- 成人Evans综合征应警惕继发因素,及时多线治疗并监测感染和血栓。
局限性
- 回顾性设计可能存在选择偏倚和信息偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Evans syndrome (ES) is a rare condition, defined as the presence of 2 autoimmune cytopenias, most frequently autoimmune hemolytic anemia and immune thrombocytopenia (ITP) and rarely autoimmune neutropenia. ES can be classified as primary or secondary to various conditions, including lymphoproliferative disorders, other systemic autoimmune diseases, and primary immunodeficiencies, particularly in children. In adult ES, little is known about clinical features, disease associations, and outcomes. In this retrospective international study, we analyzed 116 adult patients followed at 13 European tertiary centers, focusing on treatment requirements, occurrence of complications, and death. ES was secondary to or associated with underlying conditions in 24 cases (21%), mainly other autoimmune diseases and hematologic neoplasms. Bleeding occurred in 42% of patients, mainly low grade and at ITP onset. Almost all patients received first-line treatment (steroids with or without intravenous immunoglobulin), and 23% needed early additional therapy for primary refractoriness. Additional therapy lines included rituximab, splenectomy, immunosuppressants, thrombopoietin receptor agonists, and others, with response rates >80%. However, a remarkable number of relapses occurred, requiring ≥3 therapy lines in 54% of cases. Infections and thrombotic complications occurred in 33% and 21% of patients, respectively, mainly grade ≥3, and correlated with the number of therapy lines. In addition to age, other factors negatively affecting survival were severe anemia at onset and occurrence of relapse, infection, and thrombosis. These data show that adult ES is often severe and marked by a relapsing clinical course and potentially fatal complications, pinpointing the need for high clinical awareness, prompt therapy, and anti-infectious/anti-thrombotic prophylaxis.
引用
- Fattizzo B, Michel M, Giannotta JA, et al. Evans syndrome in adults: an observational multicenter study. Blood Adv. 2021. PMID: 34592758. doi:10.1182/bloodadvances.2021005610
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。